|
Title
|
|
|
|
Clostridioides difficile infection-associated cause-specific and all-cause mortality : a population-based cohort study
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Objectives: Clostridioides difficile infection (CDI) is a common healthcare-associated infection and leading cause of gastroenteritis-related mortality worldwide. However, data on CDI-associated mortality are scarce. We aimed to examine the association between CDI and all-cause and cause-specific mortality. We additionally explored contributing causes of mortality, including recurrent CDI, hospital-or community acquired CDI, chronic comorbidities, and age. Methods: This nationwide population-based cohort study (from 2006 to 2019) compared individuals with CDI with the entire Swedish background population using standardized mortality ratios. In addition, a matched-cohort design (1:10), utilizing multivariable Poisson-regression models, provided incidence rate ratios (IRRs) with 95% CIs. Results: This study included 43 150 individuals with CDI and 355 172 controls. In total, 69.7% were >65 years, and 54.9% were female. CDI was associated with a 3-to 7-fold increased mortality rate (IRR = 3.5, 95% CI: 3.3-3.6; standardized mortality ratio = 6.8, 95% CI: 6.7-6.9) compared with the matched controls and Swedish background population, respectively. Mortality rates were highest for hospital-acquired CDI (IRR = 2.4, 95% CI: 1.9-3.2) and during the first CDI episode (IRR = 0.2, 95% CI: 0.2-0.3 for recurrent versus first CDI). Individuals with CDI had more chronic comorbidities than controls, yet mortality remained higher among CDI cases even after adjustment and stratification for comorbidity; CDI was associated with increased mortality (IRR = 6.1, 95% CI: 5.5-6.8), particularly among those without any chronic comorbidities. Discussion: CDI was associated with elevated all-cause and cause-specific mortality, despite possible confounding by ill health. Mortality rates were consistently increased across sexes, all age groups, and comorbidity groups. Annelies Boven, Clin Microbiol Infect 2023;29:1424 (c) 2023 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/). |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Clinical microbiology and infection / European Society of Clinical Microbiology and Infectious Diseases. - Oxford
| |
|
Publication
|
|
|
|
Oxford
:
2023
| |
|
ISSN
|
|
|
|
1198-743X
[print]
1469-0691
[online]
| |
|
DOI
|
|
|
|
10.1016/J.CMI.2023.07.008
| |
|
Volume/pages
|
|
|
|
29
:11
(2023)
, p. 1424-1430
| |
|
ISI
|
|
|
|
001105693700001
| |
|
Pubmed ID
|
|
|
|
37473840
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|